SUBSCRIBE

Breaking News on Global Pharmaceutical Technology & Manufacturing

Top Headlines

News in brief

The US Food and Drug Administration (FDA) says compounding pharmacies must not manufacture medicines for hospitals and doctors’ offices, except for named patients.

GlaxoSmithKline will not restart production at a vaccine plant in Belgium until an independent investigation determines how liquid contaminated with polio virus was released into the local sewage system.

The $17bn (€13.2bn) acquisition of Sigma-Aldrich is “not just a milestone but a quantum leap” for Merck KGaA, the firm says.

Pfizer is working with Irish authorities to avoid a repeat of a 2013 incident when dust produced from Cork harbour entered its nearby API facility.

Global Industry News

Media moguls: Merck KGaA squares up to Thermo and GE with $17bn Sigma buy from BioPharma-Reporter.com

Merck KGaA has continued its diversification effort with a $17bn (€13bn) bid for Sigma Aldrich that will see it battle Thermo Fisher and GE Healthcare for a share of the life sciences tools and supplies market.

RLS to make India's first Remicade biosimilar for Epirus and Ranbaxy from BioPharma-Reporter.com

Reliance Life Sciences has been contracted to make the first Indian biosimilar of J&J’s Remicade (infliximab), though Epirus Biopharmaceuticals says it is looking to Fujifilm for its European supply.

Ukraine still attracting Quintiles, PPD, Icon, Parexel and INC says study from Outsourcing-Pharma.com

Political instability in Ukraine has not diminished international drug industry desire to conduct clinical trials there according to a new report.

Boehringer Ingelheim licenses CureVac mRNA vaccine for up to $600m from BioPharma-Reporter.com

Boehringer Ingelheim will pay mRNA drug developer CureVac up to €465m ($600m) for an exclusive global license and development collaboration on CureVac’s potential mRNA vaccine in early clinical development for the treatment of lung cancer. 

Research accreditation program signs off on three new organizations in US, Mexico from Outsourcing-Pharma.com

The Association for the Accreditation of Human Research Protection Programs today announced that it has accredited three more organizations, including two independent institutional review boards (IRB) in Massachusetts and a third organization in Mexico.

Covance, Frenova team to share and analyze data on CKD, renal disease from Outsourcing-Pharma.com

CRO Covance and Fresenius subsidiary Frenova Renal Research are collaborating to find more effective treatments for patients living with chronic kidney disease (CKD) and end stage renal disease (ESRD).

Spotlight

Scottish referendum: we look at Scotland's Nobel drug contributions
Feature

Nobel prizes and the world’s top drug: a gallery of Scottish pharma

On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...

‘James bond’-like tech is the end to overdoses, says formulation firm

‘James bond’-like tech is the end to overdoses, says formulation firm

Canadian drugmaker Intellipharmaceutics has developed a kill-switch formulation it says will prevent drug misuse and accidental overdoses.

Find other oral forms for tablet-hating patients, drugmakers told

Find other oral forms for tablet-hating patients, drugmakers told

Pharma firms must provide imaginative solid dosage alternatives to tablets and capsules, says research claiming more than...

Gangsters imported fake drugs from Asia says Europol

Gangsters imported fake drugs from Asia says Europol

Millions of fake pharmaceuticals seized earlier today were imported from Asia by an organised crime group that...

Compounding the problem: US warns two more pharmacies

Compounding the problem: US warns two more pharmacies

The US FDA has criticised the Compounding Shop and Zion Rx Formulations Services for making unapproved and...

Is Pfizer now eyeing up Actavis three months after failed AZ bid?
INFOGRAPHIC

Is Pfizer now eyeing up Actavis three months after failed AZ bid?

Pfizer is rumoured to be eyeing up Actavis three months after failing to woo AstraZeneca in a...

Key Industry Events

 

Access all events listing

Our events, Events from partners...